Medicare Enrolled

Dr. Shahid Aziz, M.D.

Internal Medicine · San Antonio, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
11130 CHRISTUS HILLS, San Antonio, TX 78251
2103525006
In practice since 2007 (18 years)
NPI: 1063611697 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Aziz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Aziz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Aziz

Dr. Shahid Aziz is an internal medicine in San Antonio, TX, with 18 years in practice. Based on federal Medicare data, Dr. Aziz performed 11,273 Medicare services across 2,161 unique beneficiaries.

Between the years covered by Open Payments, Dr. Aziz received a total of $208,041 from 65 pharmaceutical and/or device companies across 1519 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Aziz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ Top 3% volume in TX$ $208,041 industry payments

Medicare Practice Summary

Medicare Utilization ↗
11,273
Medicare services
Top 3% in TX for internal medicine
2,161
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~626 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Denosumab injection (Prolia/Xgeva)3,785$18$25
Chronic care management, first 20 min/month2,231$48$100
Office visit, established patient (30-39 min)1,149$88$270
Chronic care management, additional 20 min/month1,088$37$75
Remote patient monitoring device, 30 days592$38$100
Hospital follow-up visit, moderate complexity577$62$148
Face-to-face behavioral counseling for obesity, 15 minutes480$25$70
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report410$25$73
Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month394$48$100
Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month131$37$75
New patient office visit (45-59 min)71$121$318
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle67$56$132
Office visit, established patient (20-29 min)66$63$190
Ultrasound scan of head and neck soft tissue62$80$235
Initial hospital admission, moderate complexity59$101$300
Drug injection, under skin or into muscle47$11$34
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin27$47$113
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment24$105$302
Fine needle aspiration biopsy using ultrasound guidance, first growth13$106$300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$208,041
Total received (2018-2024)
Avg $29,720/year across 7 years
Top 1% in TX for internal medicine
65
Companies
1,519
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$157,771 (75.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$27,993 (13.5%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$22,277 (10.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$22,522
2023
$24,281
2022
$38,528
2021
$16,057
2020
$23,493
2019
$35,084
2018
$48,076

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Corcept Therapeutics
$66,780
SANOFI-AVENTIS U.S. LLC
$33,319
Novo Nordisk Inc
$30,283
Intuity Medical Inc
$20,112
CeQur Corporation
$9,167
Lilly USA, LLC
$8,938
Boehringer Ingelheim Pharmaceuticals, Inc.
$4,990
Zealand Pharma US, Inc.
$4,517
Mannkind Corporation
$4,507
MannKind Corporation
$3,936
Dexcom, Inc.
$3,907
Ascensia Diabetes Care Us Inc.
$3,853
AstraZeneca Pharmaceuticals LP
$2,988
Amgen Inc.
$1,579
IBSA Pharma Inc.
$1,331
Janssen Pharmaceuticals, Inc
$710
Tandem Diabetes Care, Inc.
$643
Novartis Pharmaceuticals Corporation
$595
Insulet Corporation
$549
Amarin Pharma Inc.
$394
Xeris Pharmaceuticals, Inc.
$380
Shire North American Group Inc
$367
Medtronic MiniMed, Inc.
$367
Esperion Therapeutics, Inc.
$338
Averitas Pharma Inc.
$295
AbbVie Inc.
$254
ABBVIE INC.
$237
AbbVie, Inc.
$223
BETA BIONICS, INC.
$186
RECORDATI_RARE_DISEASES_INC.
$186
Radius Health, Inc.
$181
Antares Pharma, Inc.
$164
Merck Sharp & Dohme Corporation
$160
Abbott Laboratories
$157
Horizon Therapeutics plc
$129
Becton, Dickinson and Company
$111
Ipsen Biopharmaceuticals, Inc
$110
Medtronic, Inc.
$97
Valeritas, Inc.
$92
Nevro Corp.
$81
EUSA Pharma (US) LLC
$72
Supernus Pharmaceuticals, Inc.
$65
Alexion Pharmaceuticals, Inc.
$63
Eisai Inc.
$63
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$52
Acerus Pharmaceuticals Corporation
$50
Currax Pharmaceuticals LLC
$50
Bayer HealthCare Pharmaceuticals Inc.
$43
Clarus Therapeutics Inc.
$42
Tolmar, Inc.
$38
LifeScan, Inc.
$34
Boston Scientific Corporation
$33
Takeda Pharmaceuticals U.S.A., Inc.
$30
Bigfoot Biomedical Inc
$28
Regeneron Healthcare Solutions, Inc.
$24
Amneal Pharmaceuticals LLC
$21
Companion Medical, Inc.
$19
Kyowa Kirin, Inc.
$15
DEXCOM, INC.
$15
Merck Sharp & Dohme LLC
$14
VistaPharm, Inc.
$14
Myovant Sciences Inc.
$13
PFIZER INC.
$12
KVK-Tech, Inc.
$11
GRT US Holding, Inc.
$6
Top 3 companies account for 62.7% of total payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BAQSIMI · BD NANO · BD Nano · BD Nano 2nd Gen Pen Needle · BYDUREON · Belviq · CYCLOSET · CeQur Simplicity · Crysvita · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · FARXIGA · FIASP · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GLYXAMBI · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · HUMULIN R 500 · HUMULIN U · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LINZESS · Lenvima · Levemir · MINIMED 780G · MOUNJARO · Minimed 630G · Minimed 670G System · Minimed 770G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NEXLIZET · NOCDURNA · Natesto · ORGOVYX · OT Verio Flex Starter Kit · Omnipod · OneTouch Verio Reflect · Ozempic · PNEUMOVAX 23 · PRALUENT · Pogo Automatic Blood Glucose Monitoring System · Prolia · QUTENZA · Qutenza · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · SYNJARDY · SYNTHROID · Saxenda · Senza · Sogroya · Somatuline Depot · Spectra WaveWriter · Sylvant · Synthroid · TEPEZZA · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tresiba · Tymlos · UBRELVY · UNITHROID · UNITY DIABETES MANAGEMENT SYSTEM · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · VANTA ADAPTIVESTIM · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEGALOGUE · ZEPBOUND · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (76%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for internal medicine in TX.

Equivalent to $1,845 per 100 Medicare services performed
Looking for a internal medicine in San Antonio?
Compare internal medicines in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse internal medicines nearby

Geographic Context

Internal Medicines within 10 mi
1,133
Per 100K population
55.6
County median income
$70,571
Nearest hospital
WESTOVER HILLS BAPTIST HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Aziz is a clinical cardiology specialist, with above-average Medicare volume (top 3% in TX), and high industry engagement (speaking/promotional, top 1%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Aziz experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Aziz performed 3,785 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Aziz receive payments from pharmaceutical companies?
Yes. Dr. Aziz received a total of $208,041 from 65 companies across 1,519 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Aziz's costs compare to other internal medicines in San Antonio?
Dr. Aziz's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Aziz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →